Printer Friendly
The Free Library
19,585,944 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AlphaRx Signs Milestone Agreement For Its Lead Pharmaceutical Product In Mexico.


Business Editors/Health/Medical Writers

BIOWIRE2K

RICHMOND HILL, Ontario--(BUSINESS WIRE)--Sept. 4, 2003

AlphaRx Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:ALRX) is pleased to announce that Industria Farmaceutica Andromaco S.A. de C.V. ("Andromaco") will represent AlphaRx in Mexico. Andromaco will be responsible for the manufacturing, sales, marketing and distribution of Indoflex(TM) throughout Mexico. Under the terms of the 5-year contract, Andromaco will guarantee escalating sales income to AlphaRx.

Indoflex(TM) is a topical version of the non-steroidal anti-inflammatory drug Non-steroidal anti-inflammatory drugs, usually abbreviated to NSAIDs, are drugs with analgesic, antipyretic and anti-inflammatory effects - they reduce pain, fever and inflammation.  (NSAID NSAID: see nonsteroidal anti-inflammatory drug. ) Indomethacin indomethacin /in·do·meth·a·cin/ (in?do-meth´ah-sin) a nonsteroidal antiinflammatory drug; used in the treatment of various rheumatic and nonrheumatic inflammatory conditions, dysmenorrhea, and vascular headache. . Indomethacin is used to reduce inflammation and to relieve the pain associated with rheumatoid arthritis (rheumatism rheumatism (r`mətĭzəm), general term for a number of disorders that cause inflammation and pain in muscles, bones, joints, or nerves. ), osteoarthritis, ankylosing spondylitis, and gout. One of the common side effects of NSAID use is stomach irritation. AlphaRx's patented, topical delivery system delivers Indoflex accurately and effectively to the affected area while avoiding the significant GI side effects experienced with orally ingested NSAIDS. As announced in May 2002, AlpahRx's Indoflex(TM) composition suppressed induced inflammation up to 300% when compared to Novartis' well-known and popular Emugel(TM) - currently the leading topical analgesic in the world market.

Andromaco is a well-established (1920's) pharmaceutical company headquartered in Mexico City. "We are very pleased to have Andromaco as our manufacturing partner and distributor. Through Andromaco's extensive sales and distribution channels we gain immediate access to the Mexican market for Indoflex and we will have the opportunity to use their strong market contacts in other Latin American countries." said Mr. Michael Lee, President/CEO of AlphaRx.

About AphaRx

AlphaRx uses it's patented, proprietary drug delivery system "Bioadhesive Colloidal colloidal

of the nature of a colloid.


colloidal bath
a bath containing gelatin, bran, starch or similar substances, to relieve skin irritation and pruritus.
 Dispersion" (BCD (Binary Coded Decimal) The storage of numbers in which each decimal digit is converted into binary and is stored in a single character or byte. For example, a 12-digit number would take 12 bytes. See binary numbers. ) to improve the efficacy of existing products and to develop new usable compounds for insoluble drugs and drugs that have yet to be administered to the human body. BCD has both Oral and Topical approaches that offer improved medical benefits for a broad pipeline of products with strong commercial potential. For more information please visit www.alpharx.com.

FORWARD LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Sep 4, 2003
Words:376
Previous Article:Central Parking Corporation Announces Regular Quarterly Dividend on Convertible Preferred Securities.
Next Article:Turkcell Subsidiary Intends to Buy Digital Platform.



Related Articles
Guatemala: basis for reconciliation.
QBI RECEIVES MILESTONE PAYMENT FROM MITSUBISHI-TOKYO.
AlphaRx Announces the Acquisition of a Controlling Interest in Taiwan PanBiotic Laboratories.
MEXICAN PARTIES AGREE ON REFORMS.
Telmex selects Alcatel's software platform to provide advanced services.
BIOVITRIM/SANTHERA SIGN PACT FOR DEVELOPING DPP-IV.
Astellas Pharma, MerLion Pharmaceuticals Sign Joint Research Agreement for Naturally-derived Drug Candidate Search.
Ono Pharmaceutical, Array BioPharma to Collaborate in Kinase-targeted Drug Discovery.
Takeda Pharmaceutical to Obtain Exclusive Right to Develop and Market Hematide.
MEDIVIR OUTLICENSES TWO NEW ANTIVIRAL PROJECTS TO TIBOTEC.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles